1. Home
  2. Advocacy
  3. Latest News and Practice Data
  4. Previous Advocacy Updates

Previous Advocacy Updates

  • October 19, 2021

    On October 12, over 65 pathologists participated in a “virtual fly-in” and met with their Federal policy makers to lobby Congress to mitigate a 5% Medicare cut to pathology services in 2022.

  • October 12, 2021

    The CAP has organized a “virtual fly-in” event beginning October 12 for pathologists to meet with their senators and representatives and lobby Congress to mitigate a 5% Medicare cut to pathology services in 2022.

  • October 5, 2021

    In late September, pathologists received letters from Cigna stating that the insurer would go forward with an updated payment policy on the professional component of clinical pathology it had previously tabled following opposition from the CAP.

  • September 28, 2021

    The federal government formally urged federal agencies, including the Centers for Medicare & Medicaid Services (CMS), to prepare for the possibility of a lapse in funding and government shutdown.

  • September 21, 2021

    The FDA approved the CAP for admission to its Network of Experts to provide the agency with additional expertise on pathology and laboratory medicine issues, such as those concerning the COVID-19 pandemic and artificial intelligence.

  • September 14, 2021

    The CAP successfully advocated to include new CPT codes for pathology clinical consultation services in the proposed 2022 Medicare Physician Fee Schedule but urged the CMS to clarify the codes before implementation.

  • August 31, 2021

    Building on the 21st Century Cures Act, the CAP engaged with House lawmakers to advance medical research and foster a new era of medical innovation.

  • August 19, 2021

    The CAP and the Cancer Leadership Council have called on physicians to get the COVID-19 vaccine and protect the patients they serve.

  • August 10, 2021

    A $1 trillion, bipartisan infrastructure bill passed the Senate on August 10 after months of negotiations, but associations representing physicians and other medical groups have taken issue with plans to use cuts to Medicare to partially pay for the legislation. Congress is expected to address several Medicare issues through the budget reconciliation process after elected officials return from the August recess. The CAP will be actively lobbying the Congress throughout this process on a number of issues impacting pathology.

  • August 3, 2021

    The CAP and the American Medical Association opposed the recent action taken by the Department of Veterans Affairs that nonphysicians can provide health care services.

  • July 27, 2021

    On July 22, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to import and increase the supply of “blue-top” test tubes.

  • July 20, 2021

    On July 13, the CMS released the proposed 2022 Medicare physician fee schedule by including CAP-developed pathology Consult Codes.

  • July 13, 2021

    Special Issue: The CAP successfully advocated for the inclusion of new and improved codes and values for pathology consultation services in the proposed 2022 Medicare Physician Fee Schedule.

  • July 13, 2021

    On July 1, the departments of Health and Human Services, Treasury, and Labor issued regulations implementing portions of the No Surprises Act that bars surprise billing.

  • June 29, 2021

    On June 24, bipartisan senators and representatives introduced the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, which would provide regulatory oversight of laboratory-developed tests if enacted into law. The CAP had engaged with the VALID Act’s sponsors and other stakeholders to suggest improvements to the bill over the last year.

  • June 22, 2021

    The CAP provided key recommendations for implementing the No Surprises Act to the Department of Health and Human Services as it will issue regulations and guidance before the law goes into effect January 1, 2022.

  • June 15, 2021

    The CAP urged the Department of Health and Human Services (HHS) and other key federal agencies to take immediate actions to increase the supply of sodium citrate light blue-top tubes used for coagulation testing.

  • June 8, 2021

    In response to the CAP’s engagement, Cigna informed the CAP on June 7 that the decision is imminent. The CAP learned health insurance payer Cigna plans to continue reimbursing pathologists for the professional component of clinical pathology services. A formal update regarding the policy to pay for the professional component of clinical pathology would be forthcoming soon.

  • May 25, 2021

    CAP leaders met with top officials from the Food and Drug Administration to detail its concerns about the oversight of laboratory-developed tests on May 20.

  • May 18, 2021

    A new Medicare proposal would repeal that hospitals report negotiated charges for all its Medicare Advantage, which the CAP had previously advocated against.

Analysis of Final 2020 Medicare Rule

Read the special report Right Arrow

Direct questions or comments to:

advocacyupdate@cap.org

202-354-7100

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. Right Arrow
Viewing 1-20 of 336